SARS CoV 2 Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
A
Completed
- SARS-CoV 2
- Hyperimmune plasma
- Standard of care for SARS-CoV-2 infection
- Jerez de la Frontera, Cádiz, Spain
- +13 more
2022-04-05
Apr 5, 2022M
Completed
- SARS-CoV 2
- Intramuscular Vaccine
- Montréal, Quebec, Canada
- +1 more
2022-04-04
Apr 4, 2022I
Recruiting
- COVID
- +4 more
- Antwerp, BelgiumUniversitairy hospital of Antwerp
2022-04-04
Apr 4, 2022U
Active, not recruiting
- COVID-19
- +4 more
- BCG
- Placebo
- Campinas, SP, BrazilHospital das Clínicas Unicamp
2022-03-23
Mar 23, 2022U
Completed
- Corona Virus Infection
- +3 more
- High-Titer Anti-SARS-CoV-2 (COVID 19) Convalescent Plasma
- Charlottesville, Virginia
- +1 more
2022-03-30
Mar 30, 2022E
Recruiting
- COVID-19
- +2 more
- Ipswich, United KingdomEast Suffolk and North Essex NHS Foundation Trust
2022-03-21
Mar 21, 2022U
Active, not recruiting
- COVID
- +3 more
- Data Collection
- Denver, Colorado
- +3 more
2022-03-25
Mar 25, 2022U
Active, not recruiting
- SARS-CoV 2
- Blood sampling
- Grenoble, FranceUniversityGrenobleHospital
2022-03-24
Mar 24, 2022C
Recruiting
- COVID
- +2 more
- Le Mans, FranceCentre Hospitalier Du Mans
2022-03-08
Mar 8, 2022R
U
Completed
- Covid-19
- +4 more
- Use of virus (Covid-19) genome sequence report to inform infection prevention control procedures
- London, United KingdomUniversity College London Hospitals NHS Foundation Trust
2022-02-16
Feb 16, 2022A
Recruiting
- SARS-CoV 2
- +5 more
- CAG length <22
- CAG length >=22
- Madrid, SpainHospital Universitario Ramon y Cajal
2022-02-17
Feb 17, 2022U
Active, not recruiting
- COVID-19
- SARS-CoV 2
- 10% Povidone-iodine nasal decolonization swab plus 0.12% CHG oral rinse
- Madison, WisconsinUniversity of Wisconsin-Madison
2022-02-16
Feb 16, 2022R
Completed
- SARS-CoV 2
- COVID-19
- 5-ALA-Phosphate + SFC (5-ALA + SFC)
- Manama, Bahrain
- +1 more
2022-02-08
Feb 8, 2022I
Enrolling by invitation
- Post Covid-19 Respiratory
- +2 more
- Respiratory Music Therapy Protocol
- New York, New YorkLouis Armstrong Dept. of Music & Medicine, Mount Sinai Beth Isra
2022-02-07
Feb 7, 2022H
Terminated
- COVID-19
- +3 more
- Hydroxychloroquine - Daily Dosing
- +6 more
- Detroit, Michigan
- +3 more
2022-02-07
Feb 7, 2022B
Withdrawn
- SARS-CoV 2
- Phase 1
- Phase 2
- Boston, MassachusettsBrigham and Women's Hospital
2022-01-21
Jan 21, 2022U
Active, not recruiting
- SARS-CoV 2
- +4 more
- Dallas, TexasUniversity of Texas Southwestern Medical Center
2022-02-01
Feb 1, 2022B
Terminated
- SARS-CoV 2
- +2 more
- Dose Finding Phase (MTD)
- +2 more
- Houston, TexasHouston Methodist Hospital
2022-01-04
Jan 4, 2022E
Recruiting
- SARS-CoV 2
- Hospitalisation-Associated Infection
- Stains, France
- +1 more
2022-01-03
Jan 3, 2022U
Recruiting
- SARS-CoV 2
- COVID-19
- COVID-19 Antibody testing
- Zurich, SwitzerlandEpidemiology, Biostatistics and Prevention Institute (EBPI), Uni
2021-12-09
Dec 9, 2021N
Not yet recruiting
- SARS-CoV 2
- +5 more
- ZYESAMI™ (aviptadil acetate)
- +2 more
- (no location specified)
2021-12-06
Dec 6, 2021S
Terminated
- COVID-19
- SARS-CoV 2
- Hydroxychloroquine
- Vitamin D
- Sioux Falls, South DakotaSanford Health
2021-12-08
Dec 8, 2021K
Completed
- SARS-CoV 2
- Throat swab sample for measuring current infection with SARS-CoV-2
- Blood sample for serology to measure past infection with SARS-CoV-2
- Stockholm, SwedenKarolinska University Hospital
2021-12-02
Dec 2, 2021S
Recruiting
- COVID-19
- SARS-CoV 2
- Carrageenan nasal and throat spray
- Saline nasal and throat spray
- Swansea, United KingdomJoint Clinical Research Facility
2021-12-01
Dec 1, 2021